Slingshot Pharma Appoints Steven Borr as Chief Revenue Officer

‍

Slingshot Pharma is pleased to announce the appointment of Steven Borr as Chief Revenue Officer (CRO). With an extensive background in the pharmaceutical industry, Mr. Borr brings a deep understanding of the challenges and opportunities facing the sector. His journey with Slingshot began as a customer, where he experienced firsthand how the company’s innovative software solutions streamline operations and enhance compliance.

As CRO, Mr. Borr will lead sales, marketing, and strategic growth initiatives, leveraging his industry expertise to drive Slingshot Pharma’s expansion. His unique perspective — shaped by years of working within the pharma supply chain and manufacturing sectors — positions him well to align Slingshot’s offerings with the evolving needs of pharmaceutical companies. Under his leadership, Slingshot Pharma aims to strengthen its market presence and continue delivering cutting-edge solutions that improve efficiency and regulatory compliance across the industry.